GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Equity-to-Asset

Lexagene Holdings (Lexagene Holdings) Equity-to-Asset : 0.37 (As of Nov. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Lexagene Holdings's Total Stockholders Equity for the quarter that ended in Nov. 2022 was $1.27 Mil. Lexagene Holdings's Total Assets for the quarter that ended in Nov. 2022 was $3.49 Mil. Therefore, Lexagene Holdings's Equity to Asset Ratio for the quarter that ended in Nov. 2022 was 0.37.

The historical rank and industry rank for Lexagene Holdings's Equity-to-Asset or its related term are showing as below:

LXXGQ's Equity-to-Asset is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.64
* Ranked among companies with meaningful Equity-to-Asset only.

Lexagene Holdings Equity-to-Asset Historical Data

The historical data trend for Lexagene Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Equity-to-Asset Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 0.81 0.64 0.83 0.78

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.78 0.72 0.61 0.37

Competitive Comparison of Lexagene Holdings's Equity-to-Asset

For the Medical Devices subindustry, Lexagene Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Equity-to-Asset falls into.



Lexagene Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Lexagene Holdings's Equity to Asset Ratio for the fiscal year that ended in Feb. 2022 is calculated as

Equity to Asset (A: Feb. 2022 )=Total Stockholders Equity/Total Assets
=6.38/8.198
=0.78

Lexagene Holdings's Equity to Asset Ratio for the quarter that ended in Nov. 2022 is calculated as

Equity to Asset (Q: Nov. 2022 )=Total Stockholders Equity/Total Assets
=1.273/3.49
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lexagene Holdings  (OTCPK:LXXGQ) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Lexagene Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (Lexagene Holdings) Headlines